Moreover, the diagnostic accuracies of SCAND3 and Myo1g methylation in AFP-negative HCC patients were excellent, and “SCAND3 + Myo1g” showed the best sensitivity of 92%, with an AUC of 0.857 (0.799–0.916). The gene discussed is AFP; the disease is hepatocellular carcinoma.